[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 10, 2013

Accessing Genomic MedicineAffordability, Diffusion, and Disparities

Author Affiliations

Author Affiliations: UnitedHealth Group, Minnetonka, Minnesota (Dr Tuckson); UnitedHealthcare, Minnetonka, Minnesota (Dr Newcomer); UnitedHealth Center for Health Reform & Modernization, Washington, DC (Ms De Sa).

JAMA. 2013;309(14):1469-1470. doi:10.1001/jama.2013.1468

Advances in the understanding of the genome, combined with affordable sequencing techniques and innovations in drug development, are ushering in an era of molecular diagnostics and individualized therapeutics with the potential to meaningfully enhance human health through effective prevention, diagnosis, and treatment. As the genetic origins of many diseases become better understood, risks and prognoses can be assessed based upon knowledge of genetic mutations, while biomarkers are becoming available to predict pharmacologic response in unique patients. This revolution in genomic medicine, sometimes also called personalized or precision medicine, has the ability to advance both disease prevention and patient outcomes.

First Page Preview View Large
First page PDF preview
First page PDF preview